Literature DB >> 32649631

Nocturnal blood pressure: the dark side of white-coat hypertension.

Cesare Cuspidi1,2, Federico Paoletti1, Marijana Tadic3, Carla Sala4, Elisa Gherbesi4, Raffaella Dell'Oro1, Guido Grassi1, Giuseppe Mancia1.   

Abstract

AIM: The impact of defining white-coat hypertension (WCH) and white-coat uncontrolled hypertension (WCUH) based on daytime and night-time thresholds of ambulatory blood pressure (ABP), instead of 24-h mean value, is unclear. We aimed to reclassify BP status according to both diurnal and nocturnal thresholds in a large sample of hypertensive patients seen in a specialist center and previously classified as WCH and WCUH based on 24-h BP values.
METHODS: A data-base of 7353 individual 24-h ABP monitoring (ABPM) from untreated and treated hypertensive individuals with office BP at least 140 mmHg and/or 90 mmHg was analysed and a subset of 3223 patients characterized by mean 24-h BP less than 130/80 mmHg (i.e. WCH and WCUH) was included in the present analysis.
RESULTS: As many as 1281 patients were classified as WCH and 1942 as WCUH. Among them, elevated out-of-office BP according to night-time threshold (i.e. ≥120/70 mmHg) was found in about 30% of cases. In particular, prevalence rates of nocturnal hypertension were 26.9% in WCH and 31.8% in WCUH. Isolated daytime hypertension (i.e. ≥135/85 mmHg) was detected in an additional 4% of individuals.
CONCLUSION: Classification of WCH and WCUH based on mean 24-h BP thresholds does not allow to detect an adverse BP phenotype, such as nocturnal hypertension in a large fraction of untreated and treated patients.

Entities:  

Year:  2020        PMID: 32649631     DOI: 10.1097/HJH.0000000000002541

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  1 in total

1.  Nighttime mean arterial pressure is associated with left ventricular hypertrophy in white-coat hypertension.

Authors:  Xiangyu Yang; Yuan Yuan; Qiling Gou; Runyu Ye; Xinran Li; Jiangbo Li; Jun Ma; Yanan Li; Xiaoping Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-07-06       Impact factor: 2.885

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.